COVID-19: The impact on Oncology Patients and Trials
Author: Priya Govindasamy- Director, Biostatistics & Programming Read More
Categories: Blog
“KEY-NOTE SPEECH”- Suresh Ramu
The burden of Cancer is expected to be touching 24 million new cases in the next 20 years. Even though the cases are increasi... Read More
Categories: Oncology
“CAUSAL INFERENCE AND MACHINE LEARNING FOR PHARMA REAL WORLD DATA”- Dr. Vikas Ramachandra
One of the biggest problems faced by machine learning today is that so much of real-world data is not generated in a way whi... Read More
Categories: Oncology
“CANCER RESEARCH STATISTICS- AN INDIAN PERSPECTIVE”-Dr. Jayanti Gupta
Talking about the Cancer burden in the country, India has the third highest number of cancer cases and over a million new cas... Read More
Categories: Oncology
“ROLE OF STATISTICAL PROGRAMMER IN ONCOLOGY CLINICAL TRIAL REPORTING”- Hanumantha Rao Karedla
Clinical Trials in oncology are somewhat more complicated than other therapeutic areas, A tremendous amount of research condu... Read More
Categories: Oncology
“ROLE OF BIOSTATISTICS IN ONCOLOGY DRUG DEVELOPMENT”- Veena Vincent
An increased incidence of cancer in the world has led to an increase in Oncology research. Clinical research is a critical co... Read More
Categories: Oncology
“CLINICAL PHARMACOLOGY IN ONCOLOGY CLINICAL TRIALS”- Chandrasekhar Bhupathi
The study of Clinical Pharmacology (CP) is a vital part of the drug development process. The purpose of CP trials is to study... Read More
Categories: Oncology